Repositorio Dspace

Listar01.01. Investigación y comunicación científica por tema "Infant"

Listar01.01. Investigación y comunicación científica por tema "Infant"

Ordenar por:Orden:Resultados:

  • Access to unfunded vaccination and associated socioeconomic factors in a cohort of infants from a health area of the Region of Murcia (Spain). 
    Molina-Salas, Yolanda; Romera-Guirado, Francisco-José; Sánchez-Marin, M-Del-Carmen; Navarro-Guerrero, Rosario; Romera-Guirado, María-Jesús; Pérez-Martín, Jaime-Jesús (MINISTERIO DE SANIDAD Y CONSUMO, )
    OBJECTIVE: The vaccines that are not funded by the government could create some inequities among the infants, because some of them do not have as many chances to get that immunization as others. The objective of this paper ...
  • Acute flaccid paralysis (AFP) surveillance: challenges and opportunities from 18 years' experience, Spain, 1998 to 2015 
    Masa-Calles, Josefa; Torner, Nuria; López-Perea, Noemi; Torres-de-Mier, María-de-Viarce; Fernández-Martínez, Beatriz; Cabrerizo, María; Gallardo-García, Virtudes; Malo, Carmen; Margolles, Mario; Portell, Margarita; Abadia, Natividad; Blasco, Aniceto; García-Hernández, Sara; Marcos, Henar; Rabella, Nuria; Marín, Celia; Fuentes, Amelia; Losada, Isabel; García-Gutiérrez, Juan; Nieto, Alba; García-Ortuzar, Visitacion; García-Cenoz, Manuel; Arteagoitia, José-María; Blanco-Martínez, Ángela; Rivas, Ana; Castrillejo, Daniel; Spanish, A-F-P-Surveillance-Working-Grp (EUR CENTRE DIS PREVENTION & CONTROL, 2018-11-22)
    Acute flaccid paralysis (AFP) surveillance is key for global polio eradication. It allows detecting poliovirus (PV) reintroductions from endemic countries. This study describes AFP surveillance in Spain from 1998 to 2015. ...
  • Adverse Effects Related to Paediatric Influenza Vaccination and Its Influence on Vaccination Acceptability. The FLUTETRA Study: A Survey Conducted in the Region of Murcia, Spain 
    Zornoza-Moreno, Matilde; Pérez-Martín, Jaime-Jesús; Gómez-Moreno, María-Cruz; Valcárcel-Gómez, María-del-Carmen; Pérez-Martínez, Marta; Tornel-Miñarro, Francisca-Isabel (WILEY, 2024-06)
    BackgroundDuring the 2022-23 season, three autonomous communities recommended influenza vaccination for all children between 6 and 59 months. The objective is to evaluate the adverse effects associated with the administered ...
  • Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023/24 season 
    Núñez, Olivier; Olmedo, Carmen; Moreno-Pérez, David; Lorusso, Nicola; Fernández-Martínez, Sergio; Pastor-Villalba, Pedro-Eliseo; Gutiérrez, Ángeles; García, Marcos-Alonso; Latasa, Pello; Sancho, Rosa; Mendioroz, Jacobo; Martínez-Marcos, Montserrat; Muñoz-Platon, Enrique; García-Rivera, María-Victoria; Pérez-Martínez, Olaia; Álvarez-Gil, Rosa; Wagner, Eva-Rivas; López-González-Coviella, Nieves; Zornoza-Moreno, Matilde; Barranco-Boada, María-Isabel; Pacheco, M-del-Carmen; Álvarez-Río, Virginia; Jaume, Miguel-Fiol; Arance, Roxana-Morey; Sancho, Begoña-Adiego; Méndez-Díaz, Manuel; Batalla-Rebollo, Noa; Andreu, Cristina; Castilla, Jesús; García-Cenoz, Manuel; Fernández-Ibáñez, Ana; Huerta-Huerta, Marta; Ibáñez-Pérez, Ana-Carmen; Berradre-Saenz, Belén; Lamas, Joaquín; Hermoso, Luisa; Casado-Cobo, Susana; Galán-Cuesta, Manuel; Montenegro, Sara; Domínguez, María; Jarrin, Inmaculada; Limia, Aurora; Pastor-Barriuso, Roberto; Monge, Susana (EUR CENTRE DIS PREVENTION & CONTROL, 2025-02-06)
    BackgroundRespiratory syncytial virus (RSV) causes substantial morbidity in infants < 1 year. In October 2023, Spain recommended the monoclonal antibody nirsevimab to all children born since 1 April 2023, at birth or as ...
  • Effectiveness of influenza vaccines in children aged 6 to 59 months: a test-negative case-control study at primary care and hospital level, Spain 2023/24Effectiveness of influenza vaccines in children aged 6 to 59 months: a test-negative case-control stud 
    Pérez-Gimeno, Gloria; Mazagatos, Clara; Lorusso, Nicola; Basile, Luca; Martínez-Pino, Isabel; Corpas-Burgos, Francisca; Batalla-Rebolla, Noa; Rumayor, Mercedes-Belén; Andreu-Ivorra, Blanca; Giménez-Durán, Jaume; Castrillejo-Pérez, Daniel; Guiu-Canete, Inés; Huerta-Huerta, Marta; García-Becerril, Marta; Ramos-Marín, Violeta; Casas, Inmaculada; Pozo, Francisco; Monge, Susana (EUR CENTRE DIS PREVENTION & CONTROL, 2024-10)
    During 2023/24, all children aged 6 to 59 months were targeted for seasonal influenza vaccination in Spain nationally. Using a test-negative case-control design with sentinel surveillance data, we estimated adjusted influenza ...
  • Establishing Epidemic and Intensity Thresholds After a Major Change in Respiratory Virus Surveillance in Spain in 2020 
    Puerto, Ana-María; Lozano, José-Eugenio; Lozano, Marcos; Basile, Luca; Naveira-Barbeito, Gael; Guiu-Canete, Inés; Linares-Dopido, Juan-Antonio; Fernández-Ibáñez, Ana; Ibáñez-Pérez, Ana-Carmen; Castrillejo, Daniel; Rivas-Wagner, Eva; Valcárcel-de-la-Iglesia, María-Ángel; Pérez-Morilla, Esteban; Martínez-Pino, Isabel; Vega, Tomas; Monge, Susana (WILEY, 2025-09)
    OBJECTIVES: We estimated acute respiratory infections (ARIs) and influenza-like illness (ILI) thresholds for SiVIRA, a new integrated surveillance system set up in Spain in 2020. METHODS: We retrospectively extracted ...
  • Monitoring effectiveness of nirsevimab immunization against RSV hospitalization using surveillance data: a test-negative case-control study, Spain, October 2024-March 2025 
    Campos-Mena, Sandra; Pérez-Gimeno, Gloria; Lorusso, Nicola; Álvarez-Rio, Virginia; Basile, Luca; Batalla-Rebollo, Noa; García-Comas, Luis; Andreu-Ivorra, Blanca; Pérez-Panades, Jordi; Ramos-Marin, Violeta; Castrillejo, Daniel; Fernández-Ibáñez, Ana; Rafael-de-la-Cruz-López, María-Ángeles; Núñez, Olivier; Monge, Susana (CAMBRIDGE UNIV PRESS, 2026)
    Effectiveness of nirsevimab against respiratory syncytial virus (RSV) hospitalization during the 2024/2025 season in Spain was estimated using a test-negative design (TND) and hospital-based respiratory infections surveillance ...
  • Nirsevimab Effectiveness Against Severe Respiratory Syncytial Virus Infection in the Primary Care Setting 
    López-Lacort, Mónica; Muñoz-Quiles, Cintia; Mira-Iglesias, Ainara; Xavier-López-Labrador, F; Garces-Sánchez, María; Escribano-López, Begoña; Zornoza-Moreno, Matilde; Pérez-Martín, Jaime-Jesús; Alfayate-Miguelez, Santiago; Iofrío-de-Arce, Antonio; Pastor-Villalba, Eliseo; Lluch-Rodrigo, José-Antonio; Diez-Domingo, Javier; Orrico-Sánchez, Alejandro; MEDIPRIM-Network (AMER ACAD PEDIATRICS, 2025-01-01)
    OBJECTIVES: This study assesses the effectiveness of nirsevimab, a monoclonal antibody, in preventing medically attended respiratory syncytial virus-lower respiratory tract infections (RSV-LRTIs) in a large primary care ...
  • Predictive factors of survival in people with Cystic fibrosis from a Spanish registry of rare diseases. 
    Rueda-Nieto, Senay; Mondéjar-López, Pedro; Mira-Escolano, María-Pilar; Cutillas-Tolín, Ana; Maceda-Roldán, Luis-Alberto; Arense-Gonzalo, Julián; Palomar-Rodríguez, Joaquín (MINISTERIO DE SANIDAD Y CONSUMO, )
    OBJECTIVE: In Spain, several studies describe the population with cystic fibrosis (CF) and analyze mortality trends, but few determine factors that influence survival. The objective of this study was to analyze survival ...
  • Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries 
    George, Marina; Pérez-Martín, Jaime-Jesús; AbdelGhany, Mohammad; Gkalapi, Foteini; Jamet, Nicolas; Kosse, Richelle-C; García, Yara-Ruiz; Turriani, Elisa; Berlaimont, Valerie (TAYLOR & FRANCIS INC, 2023-12-31)
    The hexavalent vaccines DT3aP-HBV-IPV/Hib and DT2aP-HBV-IPV-Hib are routinely used for primary immunization of infants against diphtheria, tetanus, pertussis, hepatitis B virus, poliomyelitis, and Haemophilus influenzae ...
  • Respiratory syncytial virus immunization with nirsevimab: Acceptance and satisfaction assessment in infants and risk groups in the region of Murcia (Spain) 
    Martin, Jaime Jesus Perez; Moreno, Maria de la Cruz Gomez; Manresa, Susana Sanchez; Abellan, Maria del Pilar Ros; Zornoza-Moreno, Matilde (TAYLOR & FRANCIS INC, 2025-12-31)
    Respiratory syncytial virus (RSV) is a leading cause of respiratory infections in infants under two years of age, often resulting in bronchiolitis and pneumonia, which contribute to high hospitalization rates. The recent ...
  • Strategies used to improve immunization coverage of nirsevimab in an autonomous community in Spain 
    Zornoza-Moreno, Matilde; Yelo-Cano, Jesús-Javier; Pérez-Martín, Jaime-Jesús (TAYLOR & FRANCIS LTD, 46387)
    Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections, particularly in infants under one year. In 2023, Spain became one of the first countries to implement nirsevimab, a long-acting ...
  • Two-season effectiveness of a single nirsevimab dose against RSV hospitalisation in healthy term-born infants: a population-based case-control study, Spain, October 2023 to March 2025 
    Núñez, Olivier; Juaneda, Juan; Martínez-Marcos, Montserrat; Muñoz-Platón, Enriqueta; Rivas-Wagner, Eva; Santiago-Pérez, María-Isolina; Álvarez-Río, Virginia; Zornoza-Moreno, Matilde; Fernández-Ibáñez, Ana; Pérez-Suárez, Gisselle; Lorono-Ortiz, Gorka; Egues, Nerea; Berradre-Saenz, Belén; Cuesta-Franco, María-de-los-Ángeles; Casado-Cobo, Susana; Domínguez-Padilla, María; Castrillejo, Daniel; Mínguez-Santiyan, Ana; Basile, Luca; Rafael-de-la-Cruz-López, María-Ángeles; Sanabria-Curbelo, Diana; Pérez-Martínez, Olaia; Rodríguez-Recio, M-Jesús; Duró-Gómez, Lourdes; Alonso-Vigil, María-del-Pilar; Méndez-Díaz, Manuel-A; Sancho, Rosa; Castilla, Jesus; Ibáñez-Pérez, Ana-Carmen; Batalla-Rebollo, Noa; Sánchez-Piorno, Lucía; López-Berrios, Ninoska; Lamas, Joaquín; Olmedo, Carmen; Monge, Susana; Pastor-Barriuso, Roberto (EUR CENTRE DIS PREVENTION & CONTROL, 2026-03-05)
    BACKGROUNDIn autumn 2023, Spain recommended nirsevimab to all infants born after 1 April 2023, as catch-up or at-birth immunisation.AIMWe estimated effectiveness of a single nirsevimab dose against respiratory syncytial ...
  • Vaccinating and non-vaccinating parents' attitudes toward influenza vaccination in children under 5 years old in Spain 
    Zornoza-Moreno, Matilde; Sánchez-Manresa, Susana; Gómez-Moreno, María-Cruz; Ros-Abellán, Maria-Pilar; Pérez-Martín, Jaime-Jesús (FRONTIERS MEDIA SA, 2025-10-01)
    BACKGROUND: Vaccines against seasonal influenza represent the best option to reduce the cases and severity of the disease in children under 5 years. In Spain, the Region of Murcia was a pioneer in implementing universal ...

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta